相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Basomedial Amygdala to Intercalated Cells Microcircuit Expressing PACAP and Its Receptor PAC1 Regulates Contextual Fear
Abha K. Rajbhandari et al.
JOURNAL OF NEUROSCIENCE (2021)
Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective
Charlotte A. Dennison et al.
SCHIZOPHRENIA RESEARCH (2020)
Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study
Rachel A. Ross et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus
Gregory C. Johnson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Activation of the VPAC2 Receptor Impairs Axon Outgrowth and Decreases Dendritic Arborization in Mouse Cortical Neurons by a PKA-Dependent Mechanism
Shuto Takeuchi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model
Xinli Tian et al.
MOLECULAR PSYCHIATRY (2019)
Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes
Dora Reglodi et al.
JOURNAL OF PATHOLOGY (2018)
PACAP deficiency as a model of aging
D. Reglodi et al.
GEROSCIENCE (2018)
Copy Number Variants in Patients with Autism and Additional Clinical Features: Report of VIPR2 Duplication and a Novel Microduplication Syndrome
Saghar Ghasemi Firouzabadi et al.
MOLECULAR NEUROBIOLOGY (2017)
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
Christian R. Marshall et al.
NATURE GENETICS (2017)
Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice
Yukio Ago et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2017)
CONSTRUCT AND FACE VALIDITY OF A NEW MODEL FOR THE THREE-HIT THEORY OF DEPRESSION USING PACAP MUTANT MICE ON CD1 BACKGROUND
Jozsef Farkas et al.
NEUROSCIENCE (2017)
Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci
Atsushi Takata et al.
NATURE COMMUNICATIONS (2017)
A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility
H. Kimura et al.
TRANSLATIONAL PSYCHIATRY (2017)
Parabrachial Pituitary Adenylate CyclaseActivating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain
Galen Missig et al.
BIOLOGICAL PSYCHIATRY (2017)
Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2
Beth Wilmot et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2016)
Genome-wide Analysis of the Role of Copy Number Variation in Schizophrenia Risk in Chinese
Zhiqiang Li et al.
BIOLOGICAL PSYCHIATRY (2016)
Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1
K. B. Mercer et al.
TRANSLATIONAL PSYCHIATRY (2016)
Pituitary Adenylate Cyclase Activating Polypeptide in Stress-Related Disorders: Data Convergence from Animal and Human Studies
Sayamwong E. Hammack et al.
BIOLOGICAL PSYCHIATRY (2015)
Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice
Katherine E. Olson et al.
JOURNAL OF NEUROSCIENCE (2015)
Vesicular Synaptobrevin/VAMP2 Levels Guarded by AP180 Control Efficient Neurotransmission
Seong Joo Koo et al.
NEURON (2015)
ATOMOXETINE REVERSES LOCOMOTOR HYPERACTIVITY, IMPAIRED NOVEL OBJECT RECOGNITION, AND PREPULSE INHIBITION IMPAIRMENT IN MICE LACKING PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE
Y. Shibasaki et al.
NEUROSCIENCE (2015)
Dendritic spine alterations in schizophrenia
Caitlin E. Moyer et al.
NEUROSCIENCE LETTERS (2015)
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist
Yukio Ago et al.
PSYCHOPHARMACOLOGY (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice
Tomris Mustafa et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2015)
Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals
Alexis Battle et al.
GENOME RESEARCH (2014)
A polygenic burden of rare disruptive mutations in schizophrenia
Shaun M. Purcell et al.
NATURE (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
A competitive PCR assay confirms the association of a copy number variation in the VIPR2 gene with schizophrenia in Han Chinese
Jianmin Yuan et al.
SCHIZOPHRENIA RESEARCH (2014)
VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair
J. A. Waschek
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Definition and refinement of the 7q36.3 duplication region associated with schizophrenia
Branko Aleksic et al.
SCIENTIFIC REPORTS (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Spatiotemporal Distribution of Vasoactive Intestinal Polypeptide Receptor 2 in Mouse Suprachiasmatic Nucleus
Sungwon An et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2012)
DISEASE MECHANISMS Genetic architectures of psychiatric disorders: the emerging picture and its implications
Patrick F. Sullivan et al.
NATURE REVIEWS GENETICS (2012)
Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
Satoko Hattori et al.
Frontiers in Behavioral Neuroscience (2012)
Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications
Douglas F. Levinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters
Mika Nishimoto et al.
BRAIN RESEARCH (2011)
VIP-induced Neuroprotection of the Developing Brain
Sandrine Passemard et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
PACAP is Implicated in the Stress Axes
Hitoshi Hashimoto et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Kerry J. Ressler et al.
NATURE (2011)
Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Vladimir Vacic et al.
NATURE (2011)
Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice
Toshihiro Ishihama et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder
Virginia Soria et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder
Ryota Hashimoto et al.
NEUROSCIENCE LETTERS (2010)
Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
Mohammed R. Milad et al.
BIOLOGICAL PSYCHIATRY (2009)
Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone
Hitoshi Hashimoto et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia
R. Hashimoto et al.
MOLECULAR PSYCHIATRY (2007)
The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis:: Focus on cerebellar granule neurones and embryonic stem cells
A. Falluel-Morel et al.
JOURNAL OF NEUROENDOCRINOLOGY (2007)
Vasoactive intestinal peptide in neurodevelopmental disorders: Therapeutic potential
Joanna M. Hill
CURRENT PHARMACEUTICAL DESIGN (2007)
Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation
Vincent Lelievre et al.
REGULATORY PEPTIDES (2006)
Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice
Kazuhiro Tanaka et al.
JOURNAL OF NEUROSCIENCE (2006)
VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice
CM Rangon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The mouse VPAC(2) receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro
DJ Cutler et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia
M Delgado et al.
GLIA (2002)
Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration
JA Waschek
DEVELOPMENTAL NEUROSCIENCE (2002)
Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)
H Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice
C Otto et al.
JOURNAL OF NEUROSCIENCE (2001)
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation
KB Nelson et al.
ANNALS OF NEUROLOGY (2001)
Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice
SB Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)